International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 129 | Views: 269

Research Paper | Oncology Science | India | Volume 6 Issue 12, December 2017 | Popularity: 6.7 / 10


     

Comparative Study of Weekly and Three Weekly Chemoradiation Regimen in Advanced Head and Neck Cancer at Silchar Medical College

Dr. Smrity R. B. Dutta, Dr. Yousuf F. Choudhury


Abstract: Majority of head and neck cancer cases present in an advanced stage and at sites where resection is not easy or it is impossible. For such cases, definitive chemoradiation is the solution. Cisplatin-based chemoradiation is the most common modality in chemoradiation in head and neck cancer world. There is a debate regarding the schedule of regimen whether weekly or three weekly regimens. With this in mind, we aim to compare the response, compliance, and toxicities of weekly low-dose cisplatin regimen and three weekly high-dose cisplatin regimen in our study. MATERIALS & METHODS 41 patients were eligible for the prospective study in the department of ENT, Silchar Medical College.24 in arm A (weekly based regimen) and 17 in arm B (three weekly based regimen) were studied for response to chemoradiation, compliance of treatment and their toxicities. The patients were divided into two arms, Arm A i. e. Cisplatin 30mg/kg body weight in one day given weekly for 6 cycles and Arm B i. e. Cisplatin 100mg/kg body weight in two days given three weekly for 3 cycles. Radiations were delivered in a fraction of 2Gy per day for 5 days per week for 6-7 weeks amounting to a total range of 60-70 Gy in both arms. RESULTS & OBSERVATIONS 70.73 % of total patients showed a complete response.75 % of weekly regimen and 64.7 % of three weekly regimens showed a complete response.79.2 %, 64.7 % of cases of weekly and three weekly regimens respectively completed their treatment. Mucositis was the most common toxicity in both arms involving all the patients. Grade III toxicities are more in arm B (64.7 %) than in arm A (41.6 %). Anemia, leucopenia, and vomiting are more in arm B than in arm A. Leucopenia in arm B is more esp. grade III and its statistically significant. CONCLUSION Toxicities are more in three weekly regimens than weekly regimen. Response and compliance are more in weekly regimen than three weekly regimens. Hence it can be concluded that weekly low-dose cisplatin regimen is superior to three weekly high-dose cisplatin regimen.


Keywords: Chemotherapy in Head and Neck cancer, Cisplatin, weekly regimen, three weekly regimens, chemotherapy toxicity


Edition: Volume 6 Issue 12, December 2017


Pages: 190 - 192



Make Sure to Disable the Pop-Up Blocker of Web Browser




Text copied to Clipboard!
Dr. Smrity R. B. Dutta, Dr. Yousuf F. Choudhury, "Comparative Study of Weekly and Three Weekly Chemoradiation Regimen in Advanced Head and Neck Cancer at Silchar Medical College", International Journal of Science and Research (IJSR), Volume 6 Issue 12, December 2017, pp. 190-192, https://www.ijsr.net/getabstract.php?paperid=ART20178636, DOI: https://www.doi.org/10.21275/ART20178636



Similar Articles

Downloads: 1

Case Studies, Oncology Science, India, Volume 11 Issue 4, April 2022

Pages: 1037 - 1041

Metachronous Lower GI Malignancies in Head and Neck Squamous Cell Carcinoma: A Case Report and Literature Review

Dr. Avinash Poojari, Dr. Rohini Khurana

Share this Article

Downloads: 124 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper, Oncology Science, India, Volume 6 Issue 9, September 2017

Pages: 91 - 96

A Comparative Study of Radiotherapy Alone and Concurrent Chemoradiation using Cisplatin as Radiosensitizer in Stage 3 and Stage 4 Nasopharyngeal Carcinoma in an Institute

Akoijam Babie Anand, Thangjam Nirpendra, Laishram Jaichand Singh

Share this Article

Downloads: 136

Research Paper, Oncology Science, India, Volume 6 Issue 8, August 2017

Pages: 1570 - 1576

A Randomised Trial of Neoadjuvant Chemotherapy in Locally Advanced Oral Cancers

Dr. Sivakumari Sivarajan, Dr. Kavitha Sukumar, Dr. Anitha.G

Share this Article



Top